Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

44.44
Delayed Data
As of Jun 23
 +0.77 / +1.76%
Today’s Change
30.89
Today|||52-Week Range
57.41
+23.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
AssetsCash2.0B2.2B2.7B2.4B
 
 
 
 
 
Short Term Investment Cash1.2B196.7M652.0M-332.9M
 
 
 
 
 
Cash & Short Term Investments2.4B2.6B3.0B2.6B
 
 
 
 
 
 
ReceivablesReceivables3.1B2.6B3.4B3.2B
 
 
 
 
 
 
InventoriesInventories2.0B2.2B2.0B2.2B
 
 
 
 
 
 
Current AssetsOther Current Assets409.2M412.6M0.000.00
 
 
 
Current Assets7.9B7.8B8.5B8.0B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross----8.2B--
 
 
Depreciation-----3.9B--
 
 
Intangible Assets314.9M430.0M385.0M398.6M
 
 
 
 
 
Other Assets314.9M430.0M385.0M398.6M
 
 
 
 
 
Total Assets13.2B13.2B13.8B13.6B
 
 
 
 
 
 
LiabilitiesAccounts Payable796.4M673.4M852.7M544.0M
 
 
 
 
 
Short Term Debt60.6M68.8M32.5M88.2M
 
 
 
 
 
Accrued Expenses----986.3M--
 
 
Other Current Liabilities4.7B4.7B4.6B5.8B
 
 
 
 
 
Other Liabilities6.2B6.3B6.7B7.0B
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes-664.4M-404.6M-378.7M-380.4M
 
 
 
 
 
Other Liabilities0.000.000.000.00
 
 
 
Total Liabilities6.8B6.9B7.4B7.8B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity6.4B6.2B6.4B5.8B
 
 
 
 
 
Total Shareholder Equity6.4B6.2B6.4B5.8B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.0B2.0B2.0B2.0B
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.